Clinical Trial Update: Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating perioperative chemotherapy including trastuzumab (Herceptin) for potentially resectable HER2-positive gastric cancer wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Liver Metastases

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hebei Medical University | Conditions: HER-2 Positive Gastric Cancer, Liver Metastasis | Phase 4 | Status: UNKNOWN